Transcatheter pulmonary valve implantation (TPVI) is a relatively new method of treatment for patients with right ventricular outflow tract (RVOT) dysfunction after surgical correction of congenital heart disease with the use of pulmonary conduit. There are only few reports of TPVI in patients in whom a surgical correction of RVOT was performed with a pericardial patch.
In the Institute of Cardiology TPVI was performed in 10 patients after surgical tetralogy of Fallot or pulmonary atresia correction of RVOT with a pericardial patch. Melody Medtronic valve (22 mm) was implanted in 3 pts. The biological Sapien-Edwards valve (23 and 26 mm) routinely used for transcatheter aortic valve implantation permited its implantation in patients with a wider RVOT.
